Salubris Biotherapeutics
Biotechnology Research • 
Gaithersburg, Maryland, United States • 21-50 Employees
Company overview
| Headquarters | 45 West Watkins Mill Road, Gaithersburg, MD 20878, US |
| Websites | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Oncology, Cardiovascular, Antibody Engineering, Antibody-Drug Conjugates, Bi-Specific Antibodies |
| Founded | 2016 |
| Employees | 21-50 |
| Socials |
Key Contacts at Salubris Biotherapeutics
Samuel Murphy
Chief Executive Officer
Michael Carrell
Director, Cmc
Alida Simon
Human Resources Director
Ashleigh Chasteen
Associate Director Of Clinical Operations
Binyam Bezabeh
Director
Huu Tich Nguyen
Sales Director
Salubris Biotherapeutics Email Formats
Salubris Biotherapeutics uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@salubrisbio.com), used 81% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@salubrisbio.com | 81% |
{first name}.{last name} | john.doe@salubrisbio.com | 19% |
About Salubris Biotherapeutics
SalubrisBio was founded in August 2016 as a subsidiary of the China-based pharmaceutical company Salubris Pharmaceuticals Co. Ltd. (www.salubris.com). SalubrisBio is an innovation-focused biotech with pioneering research and development programs. Headquartered in Gaithersburg, Maryland, SalubrisBio represents and reflects Salubris Pharmaceuticals’ commitment to innovation and expansion into the global market. SalubrisBio focuses exclusively on the discovery and global development of novel, biologic therapeutics. Salubris Pharmaceuticals is a publicly-traded company [002294:CH], founded in 1998, which has grown to achieve sales of >$750M USD in 2016. Salubris Pharmaceuticals is a fully-integrated drug development company. Headquartered in Shenzhen, China, Salubris Pharmaceuticals has over 3,000 employees working across R&D, regulatory, marketing and sales. Its marketed products include small molecule drugs in the cardiovascular, anti-allergy and anti-infective therapeutic areas. GeneKey Biotech Ltd. Co. (www.genekeybio.com), based in Chengdu, China, is the China-based biologics subsidiary of Salubris Pharmaceuticals. GeneKey Biotech has a robust portfolio of biosimilar and novel large molecule therapeutics in development in China. SalubrisBio maintains close cross-functional collaborations with GeneKey Biotech, leveraging resources including the expertise of >150 research scientists and large-scale manufacturing of up to 2000L scale.
Salubris Biotherapeutics revenue & valuation
| Annual revenue | $3,251,090 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $10,500,000 |
| Total funding | $105,000,000 |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Salubris Biotherapeutics has 10 employees across 7 departments.
Departments
Number of employees
Funding Data
Explore Salubris Biotherapeutics's funding history, including investment rounds, total capital raised, and key backers.
Salubris Biotherapeutics Tech Stack
Discover the technologies and tools that power Salubris Biotherapeutics's digital infrastructure, from frameworks to analytics platforms.
Security
Mobile frameworks
JavaScript libraries
Maps
JavaScript libraries
JavaScript libraries
JavaScript libraries
Programming languages
Blogs
Page builders
SEO
United Kingdom
Canada
New Zealand
PortugalFrequently asked questions
4.8
40,000 users
